News

AddToAny

Google+ Facebook Twitter Twitter

Genetic risk factor for stroke

Researchers have identified a common genetic variant as a risk factor for stroke – especially in patients older than 65.

Cerebral small vessel disease (SVD) causes about a quarter of ischaemic strokes worldwide and is the most common cause of vascular dementia.

SVD can manifest as lesions on the brain, which typically appear on brain scan images. It is commonly associated with ageing and hypertension, but a minority of cases are caused by cysteine-altering variants in the NOTCH3 gene. Approximately one in 300 people have this type of gene variant. A rare hereditary condition known as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), which is caused by this gene variant, has been associated with SVD and an increased risk of stroke.

In a new study, researchers evaluated a set of health records, including imaging and genomic sequencing data, of more than 300 patients, of which 118 exhibited a NOTCH3 variant. Of this group, 12.6% had a history of stroke, compared with 4.9% of those in a control group. The risk of stroke was significantly higher in those older than 65, and patients exhibited a higher number of white matter lesions on the brain. Although all 118 patients in the study group had a NOTCH3 genetic variant, the specific variant that causes CADASIL was rarely seen.

Given the high population frequency of NOTCH3 variants, the number of people who may be at higher risk of SVD and stroke as a result of a NOTCH3 variant is significant, the research team wrote. The study indicates that most individuals with a NOTCH3 variant will develop NOTCH3-associated SVD after the age of 65.  

bit.ly/3pZPOrY

Image Credit | Shutterstock

Related Articles

The big question: Are we entering a new era in which mRNA vaccines are the future?

In May, AstraZeneca began the worldwide withdrawal of its COVID-19 vaccine, due to a “surplus of updated vaccines” that target new variants. Then in June, Moderna announced positive late-stage trial results for its single COVID/flu combination vaccine, mRNA-1083. On the back of this, we look at the future impact of mRNA vaccines.

Breast cancer CREDIT - Science Photolibrary- C0584739

Predicting the return of breast cancer

Dr Isaac Garcia-Murillas discusses a new blood test that can predict if breast cancer will return years before the disease shows on scans.

Restless leg syndrome - CREDIT Science Photolibrary- C0309748

Study points to potential treatments for restless leg syndrome

Scientists have discovered genetic clues to the cause of restless leg syndrome. The discovery could help identify those individuals at greatest risk of the condition and point to potential ways to treat it.

Stem cell transplant and cellular therapy lab

My lab: stem cell transplant and cellular therapy lab

Advanced Specialist Biomedical Scientist Mel Green gives a guided tour of the stem cell transplant lab at Nottingham University Hospitals.

Top